Update: 05.10.2022
Last week: 38 week 2022 (19.09.2022 - 25.09.2022)
Last full month: Aug 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 208 300 | 9.5% | 3.7% | -0.1 | 43 626 854 | 12.4% | 3.8% | 0 | 11.3% |
| MoM | 417 416 | -10.8% | 3.8% | -2.4 | 82 975 624 | -8.9% | 3.7% | -2 | 45.5% |
| YTD | 7 539 040 | -4.7% | 5.5% | -0.6 | 1 494 076 970 | 12.2% | 5.3% | -0.2 | 5.4% |
| MAT | 12 897 668 | 16.3% | 6.0% | 0.5 | 2 453 315 522 | 35.2% | 5.6% | 0.8 | 5.7% |
| DEXALGIN | |||||||||
| WoW | 27 005 | 36.4% | 0.4% | 0.1 | 13 002 723 | 38.0% | 1.3% | 0.3 | 5.9% |
| MoM | 77 711 | -33.7% | 0.4% | -0.3 | 36 222 965 | -27.7% | 1.1% | -0.7 | 24.1% |
| YTD | 1 324 624 | 8.9% | 0.7% | 0 | 558 101 705 | 20.8% | 1.9% | 0.1 | 3.0% |
| MAT | 1 947 669 | 8.5% | 0.7% | 0 | 797 155 678 | 18.3% | 2.0% | 0.1 | 1.7% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 70 024 | 4.5% | 45.1% | -2.2 | 37 199 728 | 5.1% | 50.9% | -2.2 | 9.5% |
| MoM | 254 100 | -20.2% | 46.7% | -9 | 134 070 465 | -17.1% | 52.7% | -8.5 | -4.8% |
| YTD | 3 509 385 | -6.3% | 56.4% | -10.2 | 1 781 737 022 | 5.0% | 61.9% | -8.6 | 10.5% |
| MAT | 5 044 326 | -1.1% | 58.6% | -7.5 | 2 509 398 973 | 11.2% | 64.1% | -6.2 | 11.6% |
| ESPUMISAN BABY | |||||||||
| WoW | 28 670 | 10.6% | 33.4% | 0.4 | 18 925 808 | 12.1% | 47.2% | 0.4 | 9.4% |
| MoM | 102 195 | 2.1% | 34.4% | -3.4 | 65 631 384 | 3.4% | 47.2% | -3.3 | 12.1% |
| YTD | 1 098 742 | -10.3% | 37.9% | -4 | 683 640 098 | -4.0% | 51.3% | -5.5 | -0.7% |
| MAT | 1 537 645 | -11.3% | 38.4% | -3.3 | 943 339 595 | -3.8% | 52.1% | -3.8 | -3.7% |
| FASTUM | |||||||||
| WoW | 24 022 | 45.6% | 1.1% | 0.3 | 12 704 105 | 39.5% | 2.6% | 0.6 | 4.6% |
| MoM | 64 782 | -9.2% | 0.9% | -0.2 | 35 582 498 | -5.7% | 2.1% | -0.3 | 9.0% |
| YTD | 821 915 | -20.1% | 1.2% | -0.3 | 422 435 071 | -10.6% | 2.6% | -0.6 | 1.5% |
| MAT | 1 177 815 | -18.9% | 1.2% | -0.3 | 590 284 735 | -10.1% | 2.7% | -0.5 | 0.8% |
| IODOMARIN | |||||||||
| WoW | 77 688 | 12.4% | 23.3% | 0.1 | 14 261 861 | 11.4% | 9.9% | 0.1 | 12.0% |
| MoM | 253 124 | 17.3% | 22.1% | 0.9 | 48 433 431 | 12.6% | 9.8% | 0.1 | 12.8% |
| YTD | 2 248 797 | 5.7% | 19.4% | 0 | 447 247 407 | 11.7% | 8.8% | 0 | 5.7% |
| MAT | 3 286 981 | 24.7% | 20.6% | 2.9 | 639 331 615 | 26.4% | 9.3% | 1.1 | 7.2% |
| LIOTON | |||||||||
| WoW | 21 000 | 8.4% | 1.8% | 0 | 22 699 523 | 8.9% | 3.8% | 0.1 | 5.5% |
| MoM | 91 994 | -9.8% | 2.0% | -0.3 | 98 602 194 | -6.4% | 4.2% | -0.5 | 4.5% |
| YTD | 1 028 313 | -21.5% | 2.4% | -0.5 | 1 051 221 343 | -1.5% | 4.8% | -0.9 | -6.4% |
| MAT | 1 409 978 | -18.3% | 2.4% | -0.4 | 1 386 650 451 | 0.4% | 4.9% | -0.7 | -6.3% |
| MEZYM | |||||||||
| WoW | 245 732 | 0.1% | 18.0% | -1.2 | 36 804 295 | -2.4% | 12.4% | -1.3 | 6.6% |
| MoM | 932 880 | -26.4% | 19.7% | -7.7 | 141 473 772 | -27.8% | 13.9% | -5.9 | 2.3% |
| YTD | 14 239 601 | 1.2% | 27.6% | -0.2 | 2 178 419 268 | 10.5% | 19.8% | -1 | 2.0% |
| MAT | 20 930 758 | 8.1% | 28.9% | 1.1 | 3 115 938 050 | 15.2% | 20.9% | -0.1 | 4.1% |
| MIG 400 | |||||||||
| WoW | 178 054 | 5.3% | 2.8% | 0 | 21 115 150 | 5.2% | 2.2% | 0 | 5.9% |
| MoM | 607 220 | 2.0% | 3.0% | -0.6 | 72 302 693 | 3.7% | 2.2% | -0.3 | 24.1% |
| YTD | 6 465 035 | -9.8% | 3.4% | -0.5 | 759 870 299 | -5.8% | 2.6% | -0.5 | 3.0% |
| MAT | 9 189 194 | -3.3% | 3.4% | -0.2 | 1 070 012 157 | 0.9% | 2.7% | -0.3 | 1.7% |
| PROSTAMOL | |||||||||
| WoW | 28 493 | 11.0% | 15.2% | -0.1 | 40 103 556 | 13.2% | 16.4% | 0.1 | 11.6% |
| MoM | 84 201 | -10.2% | 15.1% | -2.8 | 118 438 306 | -8.5% | 15.9% | -2.9 | 6.5% |
| YTD | 1 215 831 | -21.9% | 19.6% | -5.6 | 1 705 835 463 | -12.4% | 20.9% | -6.7 | 0.6% |
| MAT | 1 799 738 | -15.9% | 20.6% | -4.1 | 2 459 294 890 | -7.5% | 22.0% | -5 | 0.8% |
| RESPERO MYRTOL | |||||||||
| WoW | 33 537 | 23.0% | 7.9% | 0.6 | 15 980 347 | 21.9% | 8.0% | 0.4 | 14.1% |
| MoM | 66 048 | 49.6% | 9.1% | 1.1 | 31 078 508 | 50.5% | 9.2% | 1.4 | 30.9% |
| YTD | 910 579 | 157.3% | 8.9% | 5.2 | 425 517 756 | 152.2% | 8.7% | 4.6 | 6.4% |
| MAT | 1 303 447 | 131.7% | 8.5% | 4.5 | 601 686 892 | 122.7% | 8.3% | 3.8 | 9.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 7 539 040 | -4.7% | 5.5% | -0.6 | 1 494 076 970 | 12.2% | 5.3% | -0.2 | 5.4% |
| DEXALGIN | 1 324 624 | 8.9% | 0.7% | 0 | 558 101 705 | 20.8% | 1.9% | 0.1 | 3.0% |
| ESPUMISAN (ADULTS) | 3 509 385 | -6.3% | 56.4% | -10.2 | 1 781 737 022 | 5.0% | 61.9% | -8.6 | 10.5% |
| ESPUMISAN BABY | 1 098 742 | -10.3% | 37.9% | -4 | 683 640 098 | -4.0% | 51.3% | -5.5 | -0.7% |
| FASTUM | 821 915 | -20.1% | 1.2% | -0.3 | 422 435 071 | -10.6% | 2.6% | -0.6 | 1.5% |
| IODOMARIN | 2 248 797 | 5.7% | 19.4% | 0 | 447 247 407 | 11.7% | 8.8% | 0 | 5.7% |
| LIOTON | 1 028 313 | -21.5% | 2.4% | -0.5 | 1 051 221 343 | -1.5% | 4.8% | -0.9 | -6.4% |
| MEZYM | 14 239 601 | 1.2% | 27.6% | -0.2 | 2 178 419 268 | 10.5% | 19.8% | -1 | 2.0% |
| MIG 400 | 6 465 035 | -9.8% | 3.4% | -0.5 | 759 870 299 | -5.8% | 2.6% | -0.5 | 3.0% |
| PROSTAMOL | 1 215 831 | -21.9% | 19.6% | -5.6 | 1 705 835 463 | -12.4% | 20.9% | -6.7 | 0.6% |
| RESPERO MYRTOL | 910 579 | 157.3% | 8.9% | 5.2 | 425 517 756 | 152.2% | 8.7% | 4.6 | 6.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 12 897 668 | 16.3% | 6.0% | 0.5 | 2 453 315 522 | 35.2% | 5.6% | 0.8 | 5.7% |
| DEXALGIN | 1 947 669 | 8.5% | 0.7% | 0 | 797 155 678 | 18.3% | 2.0% | 0.1 | 1.7% |
| ESPUMISAN (ADULTS) | 5 044 326 | -1.1% | 58.6% | -7.5 | 2 509 398 973 | 11.2% | 64.1% | -6.2 | 11.6% |
| ESPUMISAN BABY | 1 537 645 | -11.3% | 38.4% | -3.3 | 943 339 595 | -3.8% | 52.1% | -3.8 | -3.7% |
| FASTUM | 1 177 815 | -18.9% | 1.2% | -0.3 | 590 284 735 | -10.1% | 2.7% | -0.5 | 0.8% |
| IODOMARIN | 3 286 981 | 24.7% | 20.6% | 2.9 | 639 331 615 | 26.4% | 9.3% | 1.1 | 7.2% |
| LIOTON | 1 409 978 | -18.3% | 2.4% | -0.4 | 1 386 650 451 | 0.4% | 4.9% | -0.7 | -6.3% |
| MEZYM | 20 930 758 | 8.1% | 28.9% | 1.1 | 3 115 938 050 | 15.2% | 20.9% | -0.1 | 4.1% |
| MIG 400 | 9 189 194 | -3.3% | 3.4% | -0.2 | 1 070 012 157 | 0.9% | 2.7% | -0.3 | 1.7% |
| PROSTAMOL | 1 799 738 | -15.9% | 20.6% | -4.1 | 2 459 294 890 | -7.5% | 22.0% | -5 | 0.8% |
| RESPERO MYRTOL | 1 303 447 | 131.7% | 8.5% | 4.5 | 601 686 892 | 122.7% | 8.3% | 3.8 | 9.0% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 208 300 | 9.5% | 3.7% | -0.1 | 43 626 854 | 12.4% | 3.8% | 0 | 11.3% |
| DEXALGIN | 27 005 | 36.4% | 0.4% | 0.1 | 13 002 723 | 38.0% | 1.3% | 0.3 | 5.9% |
| ESPUMISAN (ADULTS) | 70 024 | 4.5% | 45.1% | -2.2 | 37 199 728 | 5.1% | 50.9% | -2.2 | 9.5% |
| ESPUMISAN BABY | 28 670 | 10.6% | 33.4% | 0.4 | 18 925 808 | 12.1% | 47.2% | 0.4 | 9.4% |
| FASTUM | 24 022 | 45.6% | 1.1% | 0.3 | 12 704 105 | 39.5% | 2.6% | 0.6 | 4.6% |
| IODOMARIN | 77 688 | 12.4% | 23.3% | 0.1 | 14 261 861 | 11.4% | 9.9% | 0.1 | 12.0% |
| LIOTON | 21 000 | 8.4% | 1.8% | 0 | 22 699 523 | 8.9% | 3.8% | 0.1 | 5.5% |
| MEZYM | 245 732 | 0.1% | 18.0% | -1.2 | 36 804 295 | -2.4% | 12.4% | -1.3 | 6.6% |
| MIG 400 | 178 054 | 5.3% | 2.8% | 0 | 21 115 150 | 5.2% | 2.2% | 0 | 5.9% |
| PROSTAMOL | 28 493 | 11.0% | 15.2% | -0.1 | 40 103 556 | 13.2% | 16.4% | 0.1 | 11.6% |
| RESPERO MYRTOL | 33 537 | 23.0% | 7.9% | 0.6 | 15 980 347 | 21.9% | 8.0% | 0.4 | 14.1% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 417 416 | -10.8% | 3.8% | -2.4 | 82 975 624 | -8.9% | 3.7% | -2 | 45.5% |
| DEXALGIN | 77 711 | -33.7% | 0.4% | -0.3 | 36 222 965 | -27.7% | 1.1% | -0.7 | 24.1% |
| ESPUMISAN (ADULTS) | 254 100 | -20.2% | 46.7% | -9 | 134 070 465 | -17.1% | 52.7% | -8.5 | -4.8% |
| ESPUMISAN BABY | 102 195 | 2.1% | 34.4% | -3.4 | 65 631 384 | 3.4% | 47.2% | -3.3 | 12.1% |
| FASTUM | 64 782 | -9.2% | 0.9% | -0.2 | 35 582 498 | -5.7% | 2.1% | -0.3 | 9.0% |
| IODOMARIN | 253 124 | 17.3% | 22.1% | 0.9 | 48 433 431 | 12.6% | 9.8% | 0.1 | 12.8% |
| LIOTON | 91 994 | -9.8% | 2.0% | -0.3 | 98 602 194 | -6.4% | 4.2% | -0.5 | 4.5% |
| MEZYM | 932 880 | -26.4% | 19.7% | -7.7 | 141 473 772 | -27.8% | 13.9% | -5.9 | 2.3% |
| MIG 400 | 607 220 | 2.0% | 3.0% | -0.6 | 72 302 693 | 3.7% | 2.2% | -0.3 | 24.1% |
| PROSTAMOL | 84 201 | -10.2% | 15.1% | -2.8 | 118 438 306 | -8.5% | 15.9% | -2.9 | 6.5% |
| RESPERO MYRTOL | 66 048 | 49.6% | 9.1% | 1.1 | 31 078 508 | 50.5% | 9.2% | 1.4 | 30.9% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs